Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury

Wenshuo Wang,1,* Xiaotian Sun,1,2,* Huili Zhang,3 Cheng Yang,1 Ye Liu,4,5 Wuli Yang,4,5 Changfa Guo,1 Chunsheng Wang1 1Department of Cardiac Surgery, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, 2Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, 3Depart...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang W, Sun X, Zhang H, Yang C, Liu Y, Yang W, Guo C, Wang C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/8ec079c200714213a1c00e5699638b80
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ec079c200714213a1c00e5699638b80
record_format dspace
spelling oai:doaj.org-article:8ec079c200714213a1c00e5699638b802021-12-02T07:46:33ZControlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury1178-2013https://doaj.org/article/8ec079c200714213a1c00e5699638b802016-07-01T00:00:00Zhttps://www.dovepress.com/controlled-release-hydrogen-sulfide-delivery-system-based-on-mesoporou-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wenshuo Wang,1,* Xiaotian Sun,1,2,* Huili Zhang,3 Cheng Yang,1 Ye Liu,4,5 Wuli Yang,4,5 Changfa Guo,1 Chunsheng Wang1 1Department of Cardiac Surgery, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, 2Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, 3Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University, 4State Key Laboratory of Molecular Engineering of Polymers, 5Department of Macromolecular Science, Fudan University, Shanghai, People’s Republic of China *These authors contributed equally to this work Abstract: Hydrogen sulfide (H2S) functions as a protective gas transmitter in various physiological and pathological processes, but the lack of ideal donors severely hampers the clinical application of H2S. This study aims to construct a controlled release H2S donor and evaluate its protective effect on graft endothelium. Mesoporous silica nanoparticles (MSNs) were synthesized using the sol–gel method and loaded with diallyl trisulfide (DATS), an H2S-releasing agent named DATS-MSN. In vitro experiments showed that DATS-MSN could alleviate endothelial cell inflammation and enhance endothelial cell proliferation and migration. In vivo experiments demonstrated that the apoptosis of graft endothelium was mitigated in the presence of DATS-MSN. Our results indicated that DATS-MSN, releasing H2S in a controlled release fashion, could serve as an ideal H2S donor. Keywords: inflammatory response, rejection, cellular uptake, proliferation, cardiac allograft vasculopathyWang WSun XZhang HYang CLiu YYang WGuo CWang CDove Medical Pressarticleinflammatory responserejectioncellular uptakeproliferationcardiac allograft vasculopathyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2016, Iss default, Pp 3255-3263 (2016)
institution DOAJ
collection DOAJ
language EN
topic inflammatory response
rejection
cellular uptake
proliferation
cardiac allograft vasculopathy
Medicine (General)
R5-920
spellingShingle inflammatory response
rejection
cellular uptake
proliferation
cardiac allograft vasculopathy
Medicine (General)
R5-920
Wang W
Sun X
Zhang H
Yang C
Liu Y
Yang W
Guo C
Wang C
Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
description Wenshuo Wang,1,* Xiaotian Sun,1,2,* Huili Zhang,3 Cheng Yang,1 Ye Liu,4,5 Wuli Yang,4,5 Changfa Guo,1 Chunsheng Wang1 1Department of Cardiac Surgery, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, 2Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, 3Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University, 4State Key Laboratory of Molecular Engineering of Polymers, 5Department of Macromolecular Science, Fudan University, Shanghai, People’s Republic of China *These authors contributed equally to this work Abstract: Hydrogen sulfide (H2S) functions as a protective gas transmitter in various physiological and pathological processes, but the lack of ideal donors severely hampers the clinical application of H2S. This study aims to construct a controlled release H2S donor and evaluate its protective effect on graft endothelium. Mesoporous silica nanoparticles (MSNs) were synthesized using the sol–gel method and loaded with diallyl trisulfide (DATS), an H2S-releasing agent named DATS-MSN. In vitro experiments showed that DATS-MSN could alleviate endothelial cell inflammation and enhance endothelial cell proliferation and migration. In vivo experiments demonstrated that the apoptosis of graft endothelium was mitigated in the presence of DATS-MSN. Our results indicated that DATS-MSN, releasing H2S in a controlled release fashion, could serve as an ideal H2S donor. Keywords: inflammatory response, rejection, cellular uptake, proliferation, cardiac allograft vasculopathy
format article
author Wang W
Sun X
Zhang H
Yang C
Liu Y
Yang W
Guo C
Wang C
author_facet Wang W
Sun X
Zhang H
Yang C
Liu Y
Yang W
Guo C
Wang C
author_sort Wang W
title Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
title_short Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
title_full Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
title_fullStr Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
title_full_unstemmed Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
title_sort controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/8ec079c200714213a1c00e5699638b80
work_keys_str_mv AT wangw controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT sunx controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT zhangh controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT yangc controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT liuy controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT yangw controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT guoc controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
AT wangc controlledreleasehydrogensulfidedeliverysystembasedonmesoporoussilicananoparticlesprotectsgraftendotheliumfromischemiandashreperfusioninjury
_version_ 1718399169908965376